Heart diseases claim 18 million lives annually, with atherosclerosis being a major contributor. The National University of Singapore has developed nanoparticle technology for targeted diagnosis and treatment. These nanoparticles diagnose plaques and deliver Simvastatin, reducing cardiovascular risks. Advanced techniques like IVUS and robotic-assisted surgeries further aid in early detection and personalized treatments, making atherosclerosis management more efficient.